CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-28 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −22,288 | $32.00 | $713K | 94,549 |
| 2023-12-28 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −22,288 | 503 | ||
| 2023-12-22 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion 10b5-1 | +28,310 | $23.66 | $670K | 134,348 |
| 2023-12-22 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −28,310 | $30.00 | $849K | 106,038 |
| 2023-12-22 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −28,310 | 122,680 | ||
| 2023-12-22 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −13,199 | $30.00 | $396K | 105,241 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +53,363 | $14.24 | $760K | 53,363 |
| 2023-10-27 | Lewis William Chair and CEO | Sale 10b5-1 | −53,363 | $24.04 | $1.3M | 0 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +1,322 | $14.24 | $19K | 1,322 |
| 2023-10-27 | Lewis William Chair and CEO | Sale 10b5-1 | −1,322 | $25.08 | $33K | 0 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +315 | $14.24 | $4K | 315 |
| 2023-10-27 | Lewis William Chair and CEO | Sale 10b5-1 | −315 | $26.00 | $8K | 0 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +500 | $14.24 | $7K | 500 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +55,350 | $14.24 | $788K | 289,274 |
| 2023-10-27 | Lewis William Chair and CEO | Sale 10b5-1 | −55,350 | $24.04 | $1.3M | 233,924 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +1,323 | $14.24 | $19K | 235,247 |
| 2023-10-27 | Lewis William Chair and CEO | Sale 10b5-1 | −1,323 | $25.05 | $33K | 233,924 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +327 | $14.24 | $5K | 234,251 |
| 2023-10-27 | Lewis William Chair and CEO | Sale 10b5-1 | −327 | $26.00 | $9K | 233,924 |
| 2023-10-27 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −55,000 | 500 |
Page 45 of 54 · 1,061 trades